Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Sensibility

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    58 result(s) found for: Sensibility. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2015-000882-29 Sponsor Protocol Number: 001 Start Date*: 2016-02-18
    Sponsor Name:Reinier de Graaf Groep
    Full Title: Spinal hyperbaric Prilocaine 2% 60 or 80 mg: a dosing study in day care patients.
    Medical condition: spinal anesthesia for open inguinal hernia repair or lower limb surgery
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004865 10041538 Spinal anesthesia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005891-28 Sponsor Protocol Number: CORICA Start Date*: 2008-10-04
    Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
    Full Title: Perspective evaluation on the role practiced by three different contraceptive hormonal on l I risk cardiovascular in young women: impact on the sensibility' insulinica
    Medical condition: GIOVANI DONNE TRA 18 E 35 ANNI
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036585 Pregnancy, puerperium and perinatal conditions SOC
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004033-32 Sponsor Protocol Number: RADIOMEN Start Date*: 2013-12-13
    Sponsor Name:FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
    Full Title: AN OPEN, MONOCENTRIC, NOT CONTROLLED CLINICAL TRIAL TO DEVELOP AND EVALUATE THE CLINICAL APPLICATION OF A NEW BETA PROBE FOR RADIOGUIDED SURGERY IN MENINGIOMA TUMOR
    Medical condition: SUBJECTS WITH CONVEXITY MENINGIOMA TUMORS OF NEW DIAGNOSIS
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-001869-29 Sponsor Protocol Number: 2515/2008 Start Date*: 2008-08-05
    Sponsor Name:AZIENDA OSPEDALIERA PISANA
    Full Title: Mechanism of action and metabolic effects of exenatide in obesity
    Medical condition: no diabetic, obese subjects with BMI≥40 kg.m-2
    Disease: Version SOC Term Classification Code Term Level
    9.1 10029883 Obesity LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-000940-17 Sponsor Protocol Number: 64Cu Start Date*: 2018-05-07
    Sponsor Name:
    Full Title: Phase IIa clinical study of 64 CuCl2: efficacy and safety of a new tracer for urologic tumors
    Medical condition: Genitourinary tract tumors in male patients
    Disease:
    Population Age: Elderly Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-000483-42 Sponsor Protocol Number: 001 Start Date*: 2016-05-19
    Sponsor Name:ISPPCC - CHU Chrarleroi - Hôpital Civil Marie Curie - Clinique du Sein
    Full Title: Clinical, operating, prospective, academy, study of not inferiority of the Green Indocyanine (ICG) marking method, versus the radio-isotopic method, of sentinel nodes in breast.
    Medical condition: Axillar sentinel node research in Breast Cancer staging.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-003939-27 Sponsor Protocol Number: 1-10-72-356-12 Start Date*: 2013-02-12
    Sponsor Name:Klaus Krogh
    Full Title: Objective evaluation of the effects of pasireotide on gastrointestinal and colorectal transit times, rectal wall properties, and postprandial response in patients with carcinoid diarrhea
    Medical condition: Patients with neuroendocrine tumors and carcinoid diarrhea
    Disease: Version SOC Term Classification Code Term Level
    15.1 100000004864 10062476 Neuroendocrine tumor LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-003133-33 Sponsor Protocol Number: EMG-2006 Start Date*: 2006-07-14
    Sponsor Name:Hôpital Erasme
    Full Title: Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe.
    Medical condition: healthy subjects obstructive sleep apnea (Bosentan is used in clinic in pulmonary hypertension)
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2014-001158-41 Sponsor Protocol Number: P.64CU.001.01 Start Date*: 2016-02-19
    Sponsor Name:SPARKLE SRL
    Full Title: “Technical and diagnostic performances of PET/CT with 64Cu(II)Cl2 in localization of metastases from prostate carcinoma, in patients undergoing restaging for disease progression during ADT”
    Medical condition: metastatic prostate carcinoma
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10036909 Prostate cancer metastatic PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2021-005529-25 Sponsor Protocol Number: API-EAG-2021-01 Start Date*: 2022-10-14
    Sponsor Name:ASAC Pharmaceutical Inmunology, S.A.
    Full Title: In vivo Biological Standardization of Gramineae Allergenic Extracts
    Medical condition: Biological standarization for allergenic extracts in patients with hipersensibility to extract
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021428 - Immune system disorders 10001708 Allergic conditions HLGT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-003042-47 Sponsor Protocol Number: InsulaTOP Start Date*: 2015-12-16
    Sponsor Name:Centre Hospitalier Henri Laborit
    Full Title: Psycho-biological substrates of therapeutic benefit of thermal cure on Generalized Anxiety Disorders
    Medical condition: Generalised Anxiety Disorders
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004873 10018105 Generalized anxiety disorder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-011233-27 Sponsor Protocol Number: 09/WNo02/7 Start Date*: 2009-09-10
    Sponsor Name:North Wales NHS Trust
    Full Title: Comparison of efficacy of concentration with volume of local anaesthetics in femoral-sciatic blocks for total knee replacement
    Medical condition: No medical condition or disease under investigation.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10002182 Analgesia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-011458-16 Sponsor Protocol Number: N/A Start Date*: 2009-09-10
    Sponsor Name:North Wales NHS Trust
    Full Title: Comparison of efficacy and side effects of intrathecal fentanyl with intrathecal morphine
    Medical condition: Analgesia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10002182 Analgesia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2020-001906-41 Sponsor Protocol Number: CHUBX2019/24 Start Date*: 2021-06-16
    Sponsor Name:CHU DE BORDEAUX
    Full Title: Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis
    Medical condition: joint prosthesis infection
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2006-001499-18 Sponsor Protocol Number: 26/2006/O/Sper Start Date*: 2006-05-12
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Radio-controlled Surgery RGS in the cancer of the rectum clinical study of feasibility to improve the treatment and prognosis
    Medical condition: carcinoma of the rectum
    Disease: Version SOC Term Classification Code Term Level
    8.1 10038038 Rectal cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002600-18 Sponsor Protocol Number: 43/2007/O/Sper Start Date*: 2007-06-05
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: EVALUATION OF THE RELATIONSHIP BETWEEN INFLAMMATION-PHYSICAL ACTIVITY AND THE ACTIVITY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    Medical condition: Abdominal obesity with metabolic syndrome
    Disease: Version SOC Term Classification Code Term Level
    6.1 10052066 PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2018-000089-12 Sponsor Protocol Number: HIP/FUSION#4 Start Date*: 2018-04-24
    Sponsor Name:Institut for Klinisk Medicin, Aarhus Universitet
    Full Title: Effect and safety of the iliopsoas plane block in healthy volunteers
    Medical condition: No specific medical condition is investigated. The objective of the trial is to investigate a method for postoperative analgesia after elective hip surgery.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10068084 Anesthesia procedure LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2016-001841-23 Sponsor Protocol Number: I.2016.010 Start Date*: 2016-11-16
    Sponsor Name:Banc de Sang i Teixits
    Full Title: A multicenter, randomized, open-label, two-arms phase I/II clinical trial to asses efficacy and safety of cord blood eye drops in neurotrophic keratopathy
    Medical condition: Neurotrophic Keratitis, stage 2 or 3
    Disease: Version SOC Term Classification Code Term Level
    19.0 10015919 - Eye disorders 10064996 Ulcerative keratitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-002647-18 Sponsor Protocol Number: IFCT-1102 Start Date*: 2017-10-13
    Sponsor Name:IFCT
    Full Title: phase II study evaluating the interest of the re-introduction of pemetrexed and platinum (cisplatin or carboplatin) with prolonged angiogenic blocking by bevacizumab in non squamous non small cell ...
    Medical condition: Advanced stage non squamous non small cell lung cancer
    Disease: Version SOC Term Classification Code Term Level
    15.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10025062 Lung cancer stage IV LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2011-003036-31 Sponsor Protocol Number: 01B Start Date*: 2012-03-20
    Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
    Full Title: Ministry of health integrated oncological program n°5/2006: 18F-Fluorometilcholine (18FFCH) PET/CT sensibility in diagnosis of breast cancer metastasis
    Medical condition: de novo breast cancer metastasis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10055113 Breast cancer metastatic PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 19:57:51 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA